Journal
CHEMISTRY & BIOLOGY
Volume 11, Issue 4, Pages 469-473Publisher
CELL PRESS
DOI: 10.1016/j.chembiol.2004.03.013
Keywords
-
Categories
Funding
- NCRR NIH HHS [RR 15578] Funding Source: Medline
- NIDA NIH HHS [R21 DA015173, DA 15173] Funding Source: Medline
- NIGMS NIH HHS [GM 63021] Funding Source: Medline
Ask authors/readers for more resources
A cyclic peptide, Tyr-Lys-c[-Lys-Thr-Glu(betaAla)-]-Val, incorporating a beta-Ala lactam side chain linker and designed to target the PDZ domains of the postsynaptic density protein 95 (PSD-95), has been synthesized and structurally characterized by NMR while free and bound to the PDZ1 domain of PSD-95. While bound, the lactam linker of the peptide makes a number of unique contacts outside the canonical PDZ binding motif, providing a novel target for PDZ-domain specificity as well as producing a 10-fold enhancement in binding affinity. Additionally, the cyclization greatly enhances the enzymatic stability, increasing the duration that the peptide inhibits the association between PSD-95 and glutamate receptors, effectively inhibiting the clustering of kainate receptors for over 14 hr after application. Highly specific regulation of kainate receptor action may provide a novel route for treatment of drug addiction and epilepsy.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available